Concord Biotech

Concord Biotech

Ahmedabad, India· Est.

A leading Indian biopharmaceutical company specializing in fermentation-based APIs and formulations for infectious diseases and critical care, with global CDMO services.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

A leading Indian biopharmaceutical company specializing in fermentation-based APIs and formulations for infectious diseases and critical care, with global CDMO services.

Infectious DiseaseImmunologyNephrologyHematologyRheumatology

Technology Platform

Advanced microbial fermentation and semi-synthetic chemistry for the production of complex Active Pharmaceutical Ingredients (APIs).

Opportunities

Growth driven by global API/CDMO demand, expansion into injectable formulations, and leveraging new manufacturing capacity at its Limbasi facility to serve regulated markets.

Risk Factors

Regulatory compliance risks across multiple international agencies, intense competition in the API/CDMO sector, and potential pricing pressures in generic markets.

Competitive Landscape

Competes with other Indian fermentation and CDMO specialists like Biocon and Syngene. Differentiates through deep, niche fermentation expertise, vertical integration from API to formulation, and a strong track record with global regulators.